Pharmacogenetics of Clopidogrel Response:The Basics- Describe the individual heterogeneity of patients’ responses to clopidogrel therapy. Identify causes of poor or non-responsiveness to clopidogrel therapy, including those associated with certain genetic polymorphisms. Explain the role of hepatic cytochrome P450 enzyme system, and in particular that of the enzyme CYP2C19, in the metabolism and activation of clopidogrel.
1.0 Free AMA Pra CAT 1 CME for Physicians
Expires 3/2012